For the year ending 2025-12-31, IMNM has $683,188K in assets. $48,845K in debts. $653,482K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 653,482 | |||
| Marketable securities | 0 | |||
| Prepaid expenses and other current assets | 7,295 | |||
| Total current assets | 660,777 | |||
| Property, plant and equipment, gross | 21,006 | |||
| Less accumulated depreciation and amortization | 6,370 | |||
| Property and equipment, net | 14,636 | |||
| Operating right-of-use assets | 2,978 | |||
| Restricted cash | 210 | |||
| Other long-term assets | 4,587 | |||
| Total assets | 683,188 | |||
| Accounts payable | 3,339 | |||
| Accrued expenses and other current liabilities | 41,651 | |||
| Deferred revenue, current | 0 | |||
| Total current liabilities | 44,990 | |||
| Operating lease liabilities, net of current portion | 3,855 | |||
| Total liabilities | 48,845 | |||
| Common stock, 0.0001 par value 300,000,000 shares authorized at december 31, 2025 and 2024 113,133,199 and 64,460,829 shares issued and outstanding at december 31, 2025 and 2024, respectively | 11 | |||
| Additional paid-in capital | 1,362,496 | |||
| Accumulated other comprehensive income | 0 | |||
| Accumulated deficit | -728,164 | |||
| Total stockholders' equity | 634,343 | |||
| Total liabilities and stockholders' equity | 683,188 | |||
Immunome Inc. (IMNM)
Immunome Inc. (IMNM)